Advanced Drug Delivery Systems for Targeted Cancer Therapyexplores the heterogeneity of tumors and microenvironmental factors that influence cancer treatment and contribute to drug resistance. It discusses critical elements such as tumor stroma, vasculature, pH, hypoxia, and enzymatic activity that impact therapeutic efficacy. The book covers advanced drug formulations, including supramolecular systems, metal-organic frameworks, and nanomedicine, focusing on their roles in selective drug delivery for early detection, diagnosis, and treatment of various cancers. It reviews the current status and future perspectives of these formulations, highlighting their potential to enhance therapeutic outcomes while minimizing side effects. Additionally, it examines the limitations of nanocarriers and addresses regulatory and ethical considerations related to anticancer formulations. This resource is invaluable for researchers, clinicians, and students, offering insights into the latest advancements in drug delivery systems. It bridges the gap between conventional and innovative therapies, equipping the audience with essential knowledge for developing precise cancer treatment strategies. Presents an extensive examination of various advanced drug formulations, including nanomedicine, supramolecular systems, and metal-organic frameworks, highlighting their roles in targeted cancer therapy Emphasizes the significance of the tumor microenvironment and heterogeneity in influencing drug resistance, providing insights into how these factors affect therapeutic efficacy and treatment outcomes Analyzes the limitations of current drug delivery systems, discusses regulatory considerations, and explores future perspectives in anticancer drug delivery